Department of Cell Biology, Harvard Medical
School, Boston, Massachusetts 02115,1 and
Department of Pharmacology and Molecular Biology, Finch
University of Health Sciences/The Chicago Medical School, North
Chicago, Illinois 600642
Received 24 March 1998/Returned for modification 13 May
1998/Accepted 25 May 1998
Base pairing between U2 snRNA and the branchpoint sequence (BPS) is
essential for pre-mRNA splicing. Because the metazoan BPS is short and
highly degenerate, this interaction alone is insufficient for specific
binding of U2 snRNP. The splicing factor U2AF binds to the pyrimidine
tract at the 3' splice site in the earliest spliceosomal complex, E,
and is essential for U2 snRNP binding in the spliceosomal complex A. We
show that the U2 snRNP protein SAP 155 UV cross-links to pre-mRNA on
both sides of the BPS in the A complex. SAP 155's downstream
cross-linking site is immediately adjacent to the U2AF binding site,
and the two proteins interact directly in protein-protein interaction
assays. Using UV cross-linking, together with functional analyses of
pre-mRNAs containing duplicated BPSs, we show a direct correlation
between BPS selection and UV cross-linking of SAP 155 on both sides of the BPS. Together, our data are consistent with a model in which U2AF
binds to the pyrimidine tract in the E complex and then interacts with
SAP 155 to recruit U2 snRNP to the BPS.
 |
INTRODUCTION |
The pre-mRNA splicing reaction is
carried out with extreme precision in order to generate mRNAs that
encode functional proteins. The accuracy of splicing depends on
multiple sequence elements located at the 5' and 3' splice sites, at
the branch site, and within exons. Networks of RNA-RNA, RNA-protein,
and protein-protein interactions involving each of these sequence
elements contribute to the specificity of splicing. Additional
specificity is derived from the recognition of each sequence element
multiple times prior to the two catalytic steps of splicing. These
successive recognition events occur as the spliceosomal complexes E, A,
B, and C assemble on pre-mRNA in a stepwise pathway (for reviews, see
references 17, 25, and 32).
One of the critical sequence elements in the intron is the branchpoint
sequence (BPS). This element contains an adenosine that functions as
the nucleophile for catalytic step I of splicing. Despite its key role
in splicing, the BPS is weakly conserved in metazoans, and additional
elements are required for BPS recognition. The most important of these
is the pyrimidine tract located immediately downstream from the BPS.
The splicing factor U2AF, which is composed of two subunits
(U2AF65 and U2AF35), binds to the pyrimidine
tract in the E complex, with U2AF65 directly contacting the
pre-mRNA (4, 33 [for reviews, see references
17, 25, and 32]). The essential
splicing factor SF1 (also known as mBBP) interacts with
U2AF65 and also has sequence specificity for the BPS
(2, 5, 16). Thus, this network of interactions is thought to
function in the initial recognition of the pyrimidine tract and BPS.
The BPS is recognized a second time during spliceosome assembly by
formation of a duplex between the BPS and U2 snRNA (for review, see
reference 19). This duplex is first established in
the A complex and plays an essential role in splicing by specifying the
branch-site adenosine as the nucleophile for catalytic step I
(23). Two multisubunit splicing factors, SF3a and SF3b, are components of U2 snRNP and are required for binding to the branch site
(for reviews, see references 17, 25, and
32). SF3a consists of three subunits (SAPs 61, 62, and 114), and SF3b is thought to consist of at least four subunits
(SAPs 49, 130, 145, and 155). All of the SF3a and SF3b subunits, except
SAP 130, UV cross-link to pre-mRNA in the A complex. These proteins
bind sequence independently to a 25-nucleotide (nt) region immediately
upstream of the branch site and are thought to function in part by
anchoring U2 snRNP tightly to the pre-mRNA (for reviews, see references 17, 25, and 32).
The high level of degeneracy of the mammalian BPS indicates that
specific mechanisms must exist for targeting U2 snRNP to the BPS.
U2AF65 is thought to interact directly with the BPS and
promote annealing of U2 snRNA (28). However,
U2AF65 does not specifically recognize U2 snRNA sequences.
Thus, other mechanisms must be responsible for targeting this snRNA to
the BPS. The proteins that bind to pre-mRNA in the vicinity of the BPS
early in spliceosome assembly (discussed above) are candidates for
factors involved in this process. In addition, Fleckner and coworkers
(13) identified a putative RNA helicase, UAP56, that interacts with U2AF65 and is required for U2 snRNP binding.
Other proteins that interact with pre-mRNA near or at the BPS early in
spliceosome assembly include BPS72, BPS70
(11), p80, and p14 (18, 24). None of these
proteins has been shown to play a direct role in targeting U2 snRNP to
the BPS.
In this study, we show that the SF3b and U2 snRNP component SAP 155 cross-links to pre-mRNA on both sides of the BPS in the A complex and
also can interact directly with U2AF. Moreover, cross-linking of SAP
155 in the A complex correlates with BPS selection in a pre-mRNA
containing duplicate BPSs. The SAP 155-U2AF interaction is conserved in
Schizosaccharomyces pombe, suggesting that it is
functionally important. In contrast to all other factors mentioned
above, SAP 155 is the only example of a protein with the combined
characteristics of (i) interacting with U2 snRNP, (ii) directly
contacting U2AF, and (iii) UV cross-linking to pre-mRNA immediately
next to U2AF (i.e., near the BPS). Furthermore, temporally, U2AF UV
cross-linking to the pyrimidine tract in the E complex is followed by
SAP 155 UV cross-linking on both sides of the BPS in the A complex.
Thus, together, these observations raise the possibility that
recruitment of U2 snRNP to the branch site involves binding of U2AF to
the pyrimidine tract followed by an interaction with SAP 155 to
position U2 snRNP at the BPS.
 |
MATERIALS AND METHODS |
Plasmids.
pAdML was described in reference
14. Derivatives of this pre-mRNA (see Fig. 6 and 7)
are identical to pAdML, except where indicated in the figures.
Glutathione S-transferase (GST) fusion constructs were made
by inserting the indicated sequences (see Fig. 4) into the pGEX2TK
vector (Pharmacia). S. pombe SAP 155 was cloned from an
S. pombe DNA library by PCR with oligonucleotides 5'
CGCGGATCCATGTCAACTGGTACGTATCC 3' and 5'
AAAACTGCAGTTAGATGCAAATATGTAAAG 3' and subcloned into the
BamHI and PstI sites of pGBT9 and pGAD424. The
bait and fish plasmids used in Fig. 5A and B were constructed by
insertion of the indicated sequences downstream of either the LexA DNA
binding domain in the pEG202 bait vector or the VP16 activator domain
in the fish vector pVP16. Vectors were transformed and cells were grown
on selective media (HULL, a medium lacking histidine or leucine to
select for bait and fish, respectively, and uracil and lysine to
maintain selection). The bait and fish plasmids used in Fig. 5D were
constructed by inserting the indicated sequences downstream of either
the GAL4 DNA binding domain in the bait plasmid pGBT9 (Clontech) or the
GAL4 activation domain in the fish plasmid pGAD424 (Clontech
[30]).
Far-Western analysis.
Partially purified U2AF (ppU2AF) was
prepared by mixing nuclear extract with poly(U)-Sepharose and washing
it five times in 250 mM NaCl-10 mM Tris (pH 8), followed by elution of
bound proteins with sodium dodecyl sulfate (SDS)-sample buffer
(33). Spliceosomal complexes E and A were affinity purified
as described previously (4, 27). For far-Western blots,
aliquots of nuclear extract, ppU2AF, or purified spliceosomes were
fractionated on an SDS-9% polyacrylamide gel, blotted onto
nitrocellulose or polyvinylidene difluoride membranes, and probed with
in vitro-translated (IVT) SAP 155 (35). U2AF65
and SAP 155 were IVT by using a coupled transcription-translation system (Promega). Five micrograms of RNase A was added after the translation reaction, and this mixture was then incubated for 10 min
prior to the probing of the blots.
UV cross-linking of complexes assembled on site-specifically
labeled pre-mRNA.
AdML pre-mRNAs containing a single
32P-labeled guanosine residue were synthesized by the
technique of Moore and Sharp (20) with the modifications
used by Chiara et al. (11). Spliceosomal complexes were
assembled on the site-specifically labeled pre-mRNA, fractionated by
gel filtration, and UV cross-linked (11). A 200-µl aliquot
was treated with RNase A (10 µg). After acetone precipitation,
proteins were fractionated on a SDS-polyacrylamide gel and detected by
phosphorimager (11). For immunoprecipitation of cross-linked
U2AF65, pre-mRNA site specifically labeled at the 3' splice
site (see Fig. 2, +13) was assembled into the E complex, isolated by
gel filtration, and UV cross-linked. A 500-µl aliquot of a fraction containing the E complex was incubated with RNase A (10 µg) for 30 min at 37°C. The fraction was then mixed overnight at 4°C with U2AF65 polyclonal antibodies (36) immobilized on
protein A-Trisacryl beads. After being washed with 500 mM NaCl and 1%
Nonidet P-40, total bound protein was fractionated on a 9% SDS gel.
GST pull down assays.
GST fusion proteins were expressed in
Escherichia coli, bound to glutathione-Sepharose beads, and
incubated for 1 h at 4°C with 25 µl of nuclear extract. Each
sample was washed six times with NETN (0.5% Nonidet P-40, 20 mM Tris
[pH 8], 100 mM NaCl, 1 mM EDTA, 2 mM phenylmethylsulfonyl fluoride).
Bound proteins were eluted in protein sample buffer, fractionated on
SDS gels, transferred to polyvinylidene difluoride membranes, and
probed with the indicated antibodies.
Yeast two-hybrid assays.
For Fig. 5A and B,
-galactosidase filter lift assays were used to test for two-hybrid
interactions (12). All interactions that are denoted as
positive turned blue in 10 or greater independent assays compared to
the negative control at the same time point. For Fig. 5D, interactions
were assayed as described by Wentz-Hunter and Potashkin
(30).
Splicing assays.
Splicing reaction mixtures (25 µl)
containing 32P-labeled pre-mRNAs (20 ng) were incubated
under standard splicing conditions for 45 min. Total RNA was isolated
and separated on polyacrylamide denaturing gels. For native gel
analysis, sample dye containing 2.5 mg of heparin per ml was added to
splicing reactions mixtures, which were then fractionated on 4%
polyacrylamide nondenaturing gels.
 |
RESULTS |
SAP 155 interacts with pre-mRNA on both sides of the BPS.
To identify splicing factors involved in targeting U2 snRNP to
the BPS, we analyzed proteins that UV cross-link to
pre-mRNA in the vicinity of the BPS in spliceosomal complex
A. Pre-mRNAs were site-specifically labeled with 32P
at guanosines located 6 nt upstream (
6) or 5 nt
downstream (+5) of the branch-site adenosine (Fig.
1A), assembled into the A complex,
and then isolated by gel filtration (see Materials and
Methods). As shown in Fig. 1B (lane
6), and consistent with previous
work (15), the SF3a component SAP 62 and the SF3b component SAP 155 cross-link at the
6 site (low levels of hnRNP I from contaminating H complex are also detected at
6 [Fig. 1B,
6]). A
single high-molecular-weight protein, comigrating with SAP 155 on SDS
and two-dimensional gels, was detected at +5 (Fig. 1B and C, +5). This
protein does not cross-link at
1 (11) (see Fig. 7C). In
addition, the +5 and
6 cross-linked proteins are present in
affinity-purified A complex and comigrate with SAP 155 on
two-dimensional gels (reference 15 and data not
shown). We conclude that SAP 155 UV cross-links to pre-mRNA on both
sides of, but not directly at, the BPS in the A complex.
Coomassie-stained gels show that SAP 155 is equimolar with the other
high-molecular-weight U2 snRNP proteins in the A complex (data not
shown). Assuming that these proteins all bind to pre-mRNA as monomers,
a single SAP 155 monomer may contact both sides of the BPS. We cannot
exclude the alternative possibility that there is a mixture of A
complexes in which SAP 155 binds upstream of the BPS in one population
and downstream of the BPS in another population. However, we have
obtained no evidence for a temporal order of SAP 155 cross-linking at
either the upstream or downstream site during spliceosome assembly
(data not shown).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 1.
U2 snRNP protein SAP 155 UV cross-linking to pre-mRNA on
both sides of the branch site. (A) Schematic of pre-mRNA. The
nucleotide sequence of the 3' portion of the AdML intron is shown. The
BPS and AG dinucleotide at the 3' splice site are in boldface, and the
BPS is also underlined. The arrows indicate the G residues that were
labeled, and the numbers are relative to the branch-site adenosine. (B)
Pre-mRNAs labeled at 6 or +5 were assembled into the A complex,
isolated by gel filtration, and UV cross-linked. After treatment with
RNase A, proteins were fractionated on a 9% SDS gel (equal counts per
minute of each pre-mRNA were loaded). The positions of SAPs 155 and 62 and hnRNP I are indicated. hnRNP I cross-linking is due to
contamination of the A complex with the H complex in this experiment.
(C) The +5 cross-linked sample was fractionated on a 6% SDS gel next
to the A complex and next to the A complex separated in two dimensions.
The A complex samples were detected by staining and the +5 cross-link
(xlink) was detected by phosphorimager.
|
|
U2AF65 UV cross-links immediately downstream of SAP 155 in the A complex.
To identify proteins near SAP 155 on the
pre-mRNA in the A complex, we site-specifically labeled pre-mRNA 10 nt
downstream from the branch site. Only SAP 155 was detected at this
site, and the level was extremely low relative to that detected at +5 and
6 (data not shown). In contrast, when pre-mRNA was labeled at a
site 13 nt from the branch site (Fig. 2A,
+13), one major band, which cofractionates with IVT U2AF65,
was detected in both the E and A complexes (Fig. 2B, lanes E and A)
(33, 34). As expected (33, 34), this cross-linked band is specifically immunoprecipitated by antibodies to
U2AF65 (Fig. 2C, lane IP), but not by control antibodies
(data not shown).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 2.
U2AF65 UV cross-linking next to SAP 155 in
the A complex. (A) Nucleotide sequence of the 3' portion of the AdML
intron. The arrow indicates the G residue that was site-specifically
labeled. The SAP 155 cross-linking sites in the A complex are
indicated. At the +13 site, the UU was changed to GC in order to
transcribe the 3' RNA for site-specific labeling (see Materials and
Methods). This alteration has no effect on A complex assembly or
splicing. (B) The proteins that cross-link at the +13 site in the H, E,
and A complexes are shown next to IVT U2AF65 (as a marker).
(C) Pre-mRNA site-specifically labeled at +13 was assembled into the E
complex and UV cross-linked, and then an immunoprecipitation (IP) with
U2AF65 antibodies was carried out. IVT U2AF65
was run as a marker.
|
|
U2AF65 cross-linking was detected at similar levels in the
E and A complexes (Fig. 2B, compare lanes E and A). This is consistent with previous work showing that U2AF65 is detected in both
the E and A complexes when they are isolated by gel filtration alone
and assayed by UV cross-linking (8). (Note that when the
complexes are isolated by the more stringent two-step gel
filtration-affinity chromatography procedure, U2AF65 is
detected at much lower levels in the A complex than in the E complex
[4]. Thus, together, these data indicate that
U2AF65 undergoes a conformational change during the E-to-A
complex transition.) We conclude that SAP 155 is the closest
cross-linked protein upstream of U2AF65 on the pre-mRNA in
the A complex.
U2AF and SAP 155 interact directly.
The observation that SAP
155 and U2AF65 UV cross-link to adjacent sites on the
pre-mRNA in the A complex raised the possibility that these proteins
may interact with each other directly. To test this possibility, we
used IVT SAP 155 to probe a far-Western blot containing nuclear
extract, purified E complex, purified A complex, or a partially
purified preparation of U2AF (ppU2AF; see Materials and Methods and
reference 33). (Note that RNase A was added to the
probes to disrupt the potential for RNA-mediated interactions.) An ink
stain of the blot shows that there are a large number of proteins in
each lane (Fig. 3C). Significantly, the
IVT SAP 155 probe detects only two main bands in the E complex and in
ppU2AF (Fig. 3A). The same two proteins were also detected by
antibodies to U2AF65 and U2AF35 (Fig. 3B).
Neither the SAP 155 probe nor the U2AF antibodies detected bands in the
A complex (Fig. 3A and B), consistent with studies showing that U2AF is
largely dissociated from the affinity-purified A complex
(4 [also see above]). The observation that SAP 155 interacts with U2AF65 and U2AF35 on the
far-Western blot and does not interact with a very large number of
other abundant proteins present on this blot indicates that the SAP
155-U2AF65 and the SAP 155-U2AF35 interactions
are specific. In addition, when IVT-U2AF65 was used to
probe a far-Western blot containing the purified A complex, only SAP
155 was detected (data not shown). Thus, SAP 155 is the only U2 snRNP
protein detected by U2AF.

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 3.
U2AF and SAP 155 interact directly. (A) IVT SAP 155 (aa
148 to 775) was used to probe a blot containing nuclear extract (NE), E
complex, A complex, or partially purified U2AF (ppU2AF).
U2AF65 and U2AF35 are indicated. (B) The blot
in panel B was probed with U2AF65 and U2AF35
antibodies ( ) (Western blotting). (C) An ink stain of the blot
probed in panels A and B.
|
|
The SAP 155 probe detected several proteins when a large amount of
total nuclear extract was used for the far-Western analysis (Fig. 3A
and C, NE). However, it is unlikely that these interactions are
specific. This conclusion is based on two-dimensional far-Western analysis, which revealed that the SAP 155 probe detects the proteins that are among the most abundant in the nuclear extract (data not
shown). None of the proteins detected by SAP 155 in the total extract
appears to correspond to known spliceosomal proteins, and Western
analysis shows that they do not correspond to the SR family of splicing
factors (data not shown). Other spliceosomal proteins, such as the
components of SF3a and -b, detected only single proteins on far-Western
blots of nuclear extract (3, 10). However, the proteins in
the SF3a and SF3b complexes are tightly associated in stable complexes
that copurify over multiple chromatographic steps and are not disrupted
under very-high-salt conditions (reference 7 and
unpublished observations). The observation that SAP 155 is a
less-specific probe on far-Western blots than the SF3a and -b
components may be mechanistically important, since the SAP 155-U2AF
interaction is expected to be lower affinity so that it can be
disrupted prior to catalytic step II of splicing (9).
To demonstrate SAP 155-U2AF interactions by another method and delimit
a region of SAP 155 necessary for interactions with U2AF, GST fusion
proteins containing different portions of SAP 155 were constructed
(Fig. 4A). These proteins were coupled to glutathione beads and mixed with nuclear extract (containing RNase A).
After extensive washing, the bound proteins were fractionated on a gel,
and Western blot analyses were carried out. A Coomassie-stained gel of
the SAP 155 and control GST fusion proteins is shown in Fig. 4B. As
reported previously (2), GST-SF1/mBBP (amino acids [aa] 1 to 361) pulls down both U2AF65 and U2AF35 (Fig.
4C, lane 1). Similarly, aa 1 to 480 or 267 to 369 of SAP 155 pull down
both U2AF65 and U2AF35 (Fig. 4C, lanes 2 and
4). In contrast, GST alone, GST fused to random amino acids, or a GST
fusion protein containing SAP 155 aa 370 to 485 does not interact with
either U2AF subunit (Fig. 4C, lanes 3, 5, and 6). A GST fusion protein
containing the SAP 155 carboxy terminus also does not interact with
U2AF (data not shown).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 4.
A specific amino-terminal region of SAP 155 is
sufficient to mediate the interaction with U2AF. (A) Structure of SAP
155. The amino-terminal RWDETP and TPGH repeats and carboxy-terminal
PP2A-like repeats are shown (29). Numbers indicate amino
acids. The portions of SAP 155 that were used to make fusion proteins
are indicated. (B) Coomassie stain of GST fusion proteins. Markers are
indicated to the left in kilodaltons. (C) Lanes 1 to 6: GST fusion
proteins bound to glutathione beads were incubated with a 25-µl
aliquot of nuclear extract and washed, and then Western analysis of the
bound proteins was carried out. Total nuclear extract (NE) (4 µl) is
shown in lane 7. The blot was probed successively with
U2AF65, U2AF35, and SAP 130 antibodies.
|
|
The blot shown in Fig. 4C was reprobed with antibodies to the U2 snRNP
protein, SAP 130 (as a negative control). SAP 130, which was detected
in total nuclear extract (Fig. 4C, lane 7), was not detected
significantly with any of the GST fusion proteins (Fig. 4C, lanes 1 to
6). Furthermore, two additional spliceosomal proteins (hSLU7 and
hPRP16) were also not detected with GST-SAP 155 (data not shown). Thus,
these data indicate that SAP 155 and U2AF interact specifically with
each other in total nuclear extract. Moreover, a distinct domain on SAP
155, extending from aa 267 to 369, is necessary and sufficient for this
interaction with U2AF. Interestingly, this domain contains several
repeats of the sequence RWDETP and a large number of TPGH repeats which
are potential phosphorylation sites (29).
To determine whether U2AF and SAP 155 can also interact in vivo, yeast
two-hybrid assays were carried out. An amino-terminal portion of SAP
155 (aa 171 to 775) was fused to the activation domain of VP16 and used
as a fish construct. SAP 155 fused to the LexA DNA binding domain could
not be used as a bait construct because it transactivates the
-galactosidase promoter in the absence of a fish construct (data not
shown). By using the SAP 155 fish construct, interactions with
full-length U2AF65 and U2AF35 baits were
detected (Fig. 5A, left panel, column 1).
No interaction was detected with U2AF35 lacking its RS
domain (Fig. 5A, left panel, column 1). In contrast, U2AF65
interacts with both U2AF35 and U2AF35
RS, as
previously reported (35) (Fig. 5A, left panel, column 2).
With U2AF65 as a bait, interactions with SAP 155 and
U2AF35 were detected, whereas no interactions were detected
with the VP16 construct alone (Fig. 5A, right panel). Interactions
between U2AF65 and U2AF35 were detected at 10 min, whereas SAP 155-U2AF interactions were detected at 15 min. In
contrast, no interactions were detected in control experiments for at
least 3 h (data not shown). We conclude that SAP 155 interacts
with both subunits of U2AF in the two-hybrid assay, confirming the
interactions detected by far-Western analysis (Fig. 3).

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 5.
Analysis of the SAP 155-U2AF interaction by the yeast
two-hybrid assay. (A) -Galactosidase filter lift assays were done
with cells transformed with the indicated bait and fish vectors. (B)
Structure of U2AF65 and derivatives of U2AF65
that were used as baits for two-hybrid assays. U2AF35 and
SAP 155 (aa 171 to 775) were used as fish. The interactions were
assayed with the -galactosidase filter assay. +, interactions
between the fish and bait (blue color production on the filter). , no
interaction (relative to the VP16 negative control). (C) The percent
identity between Homo sapiens, S. pombe, and
S. cerevisiae SAP 155, U2AF35,
U2AF65 homologs is shown. (D) Two-hybrid assays of S. pombe (sp) U2AF65, U2AF35, and SAP 155. The fish and baits are indicated. As with human SAP 155, S. pombe SAP 155 used as a bait transactivates the -galactosidase
( -gal) promoter in the absence of a fish construct.
|
|
A specific region containing the third RRM of U2AF65
mediates the interaction with SAP 155.
An amino-terminal region
(aa 64 to 182) of U2AF65 is required for the interaction
with U2AF35 (35), the Arg-Ser-rich (RS) domain
(aa 25 to 91) of U2AF65 promotes annealing of U2 snRNA to
pre-mRNA (28), aa 138 to 183 of U2AF65 interact
with UAP56 (13), and a region containing the third RRM (aa
334 to 475) of U2AF65 interacts with SF1/mBBP
(6). To define the domain on U2AF65 required for
the interaction with SAP 155, derivatives of U2AF65 were
used as baits (Fig. 5B) to test interactions with three different fish
containing U2AF35, SAP 155, or VP16 alone (as a negative
control) (Fig. 5B).
-Galactosidase activity in liquid culture was
quantified for a subset of these bait-fish combinations and confirmed
the data obtained from assays on plates (data not shown). As shown in
Fig. 5B, and consistent with previous work (35), aa 91 to
151 of U2AF65 are sufficient for the interaction with
U2AF35, and derivatives of U2AF65 lacking this
domain do not interact with U2AF35 (Fig. 5B, row 14, and
rows 8 to 12, respectively; we note that a U2AF65
derivative containing aa 91 to 229 failed to interact with
U2AF35 despite containing the
U2AF35-interaction domain [row 15]. This protein is
expressed in yeast, but could be improperly folded because of the
additional sequences.)
Amino acids 334 to 475 of U2AF65 are sufficient for the
interaction with SAP 155 (Fig. 5B, row 9). The region between aa 334 and 392 is required, since a construct containing only aa 392 to 475 fails to interact with SAP 155 (Fig. 5B, row 8). Similarly, aa 392 to
475 are required, since a construct containing aa 1 to 392 does not
interact with SAP 155 but does still interact with U2AF35.
We conclude that a specific domain of U2AF65, which
contains the third RRM, is required for the interaction with SAP 155. Significantly, this region of U2AF65 also interacts with
SF1/mBBP (6). Because SF1/mBBP binds to pre-mRNA in the E
complex, whereas SAP 155 does not bind until the A complex, it is
possible that there is an exchange of SF1/mBBP for SAP 155 during the
E-to-A complex transition.
For U2AF35, the RS domain is required for the interaction
with SAP 155. Because U2AF35 lacks an RRM and is not
significantly similar to U2AF65, it is likely that
structurally distinct domains of U2AF65 and
U2AF35 interact with SAP 155.
SAP 155-U2AF65 interactions are conserved in S. pombe.
As shown in Fig. 5C, SAP 155, U2AF65, and
U2AF35 are conserved in S. pombe (22, 29,
30). In addition, S. pombe SAP 155 contains two of the
amino-terminal RWDETP motifs that are present in the U2AF interaction
domain of human SAP 155 (see Fig. 4A). In contrast, the amino terminus
of Saccharomyces cerevisiae SAP 155 is not conserved
(29), and there is no homolog for U2AF35 in
S. cerevisiae. The high level of sequence conservation of U2AF and SAP 155 between S. pombe and humans prompted us to
test the possibility that SAP 155-U2AF interactions also occur in
S. pombe. An S. pombe SAP 155 fish construct was
tested with S. pombe U2AF65 (U2AF59)
and U2AF35 (U2AF23) baits. As shown in Fig. 5D,
the interaction between S. pombe SAP 155 and
U2AF59 does indeed occur. In contrast, the
U2AF35-SAP 155 interaction is not conserved (Fig. 5D).
Interestingly, despite the high similarity between S. pombe
U2AF23 and U2AF35 (Fig. 5C), U2AF23
lacks an RS domain. As suggested above, the RS domain of
U2AF35 is required for U2AF35-SAP 155 interactions.
Parameters for U2 snRNP binding.
The data presented above show
that U2AF and SAP 155 interact directly in both humans and S. pombe and that SAP 155 cross-links on both sides of the BPS (in
humans). Because U2AF binding precedes SAP 155 (and U2 snRNP) binding
during spliceosome assembly, one possible role for these RNA-protein
and protein-protein interactions is in recruiting U2 snRNP to the BPS.
In this recruitment step, U2AF bound to the pyrimidine tract may
contact SAP 155 to position and/or stabilize U2 snRNP at the BPS.
Because SAP 155 and SF1/mBBP both interact with the same domain on
U2AF65 and because this domain is involved in
U2AF65-pre-mRNA interactions (references
6 and 34 and this study), it is
not possible to use mutant U2AF65 lacking the interaction
domain to test the functional significance of the SAP
155-U2AF65 interaction. Thus, in order to gain further
insight into the mechanism for recruiting U2 snRNP, we investigated the
parameters in the pre-mRNA that are important for U2 snRNP binding.
Previous work indicated that the distance between the pyrimidine tract
and BPS is critical for catalytic step I of the splicing reaction
(26, 27a). To determine whether this distance is also important for U2 snRNP binding, we constructed a pre-mRNA, designated 2far, in which a 27-nt spacer was inserted between the BPS and U2AF65 binding sites (Fig. 6, see schematic). This spacer
lacks adenosines because of their potential to function as cryptic
branch sites. Comparison of spliceosome assembly with wild-type versus
2far pre-mRNA shows that this insertion dramatically decreases A
complex assembly (Fig. 6). In contrast, E
complex assembly on wild-type and 2far pre-mRNAs occurs with the same
efficiency (data not shown). The observation that the E complex can
assemble on 2far pre-mRNA indicates that the block to A complex
assembly is unlikely to be due to a general negative effect of the
insertion sequence. These data indicate that the distance between the
BPS and pyrimidine tract is a critical parameter for U2 snRNP binding.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 6.
The distance between the BPS and pyrimidine (py) tract
is critical for A complex assembly. A spacer of the sequence indicated
was inserted immediately downstream of the BPS to generate the pre-mRNA
2far. The distance between the BPS and 3' splice site is 52 nt. 2far or
wild-type pre-mRNA was incubated under splicing conditions for the
times indicated (in minutes) and then fractionated on a native gel. The
H, A, and B complexes are indicated.
|
|
We next asked whether the proximity of the BPS to the pyrimidine tract
is important for BPS selection. To test this parameter, pre-mRNAs
containing tandemly duplicated BPSs were constructed (Fig.
7). In the first set of experiments, both
BPSs were located within the BPS-to-AG distance that is normally found
in metazoan pre-mRNAs (18 to 40 nt) (Fig. 7A). Pre-mRNAs containing a G
substitution for the branch-site A were used to generate markers for
the lariats. Only the downstream BPS was used when the upstream BPS
contained a G (Fig. 7A, lane G/A), and only the upstream BPS was used
when the downstream BPS contained a G (Fig. 7A, lane A/G). However, when both BPSs contained an A, and thus were in direct competition, lariat formation occurred primarily at the downstream BPS (Fig. 7A,
lane A/A). These data show that the BPS closest to the pyrimidine tract
is preferentially selected. This result, together with the observation
that the distance between the BPS and pyrimidine tract is critical for
U2 snRNP binding (Fig. 6), supports a model for U2 snRNP binding in
which a factor(s) bound at the BPS interacts with a factor(s) bound at
the pyrimidine tract. Moreover, there must be a mechanism for
constraining the interaction linearly along the RNA, since the BPS and
pyrimidine tract must be located adjacent to each other for efficient
U2 snRNP binding and BPS selection. A model of U2 snRNP binding that
incorporates these data is presented below (see Discussion).

View larger version (21K):
[in this window]
[in a new window]

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 7.
SAP 155 cross-linking to pre-mRNA correlates with BPS
selection (A) The BPS closest to the 3' splice site is selected. The
structures of pre-mRNAs containing duplicated BPSs are shown. Pre-mRNAs
were incubated under splicing conditions for 40 min, and total RNA was
fractionated on a 15% polyacrylamide denaturing gel. The bands
corresponding to spliced products and intermediates are indicated. (B)
An optimal distance between the BPS and 3' splice site is necessary for
BPS selection. The structures of pre-mRNAs containing duplicated BPSs
are indicated. The branch-site adenosine is in boldface, and the
distance from this adenosine to the 3' splice site is shown. The
pre-mRNAs were incubated under splicing conditions for 45 min, and then
total RNA was fractionated on a 13% polyacrylamide denaturing gel. The
splicing intermediates and products are indicated. (C) SAP 155 UV
cross-links on both sides of the functional BPS.
A22/A14 pre-mRNA was 32P
site-specifically labeled at the indicated guanosines, assembled into
the A complex, isolated by gel filtration, and UV cross-linked. After
RNase A treatment, cross-linked proteins were fractionated by
SDS-polyacrylamide gel electrophoresis, and cross-linked proteins were
detected by phosphorimager analysis. SAPs 155 and 62 are indicated.
|
|
An optimal distance between the BPS and pyrimidine tract for
branch-site selection.
To determine whether the BPS nearest to the
pyrimidine tract is always selected or whether there is an optimal
distance between the BPS and pyrimidine tract, we constructed a
pre-mRNA containing duplicated BPSs in which the downstream BPS is
located directly adjacent to the run of U's where U2AF binds and the
upstream BPS is located 8 nt further upstream. The branch sites are
located 14 and 22 nt upstream from the 3' splice site in this construct (Fig. 7B, schematic, A22/A14). Pre-mRNAs
containing G substitutions for either BPS were used to generate markers
for the lariats (Fig. 7B, schematic, G22/A14
and A22/G14). Significantly, the upstream BPS
is preferentially used in A22/A14 pre-mRNA
(Fig. 7B, lane A/A). Moreover, when there is a G substitution in the
upstream BPS, lariat formation occurs at the downstream BPS but is much
less efficient (Fig. 7B, compare lanes G/A versus A/A). Thus, from the
analyses shown in Fig. 7A and B, we conclude that the BPS nearest to
the 3' splice site is preferentially selected, but it cannot be located
too close to the 3' splice site. Although other explanations are
possible, a reasonable interpretation of these data is that there are
steric constraints on the factors bound at the pyrimidine tract and
those bound at the BPS.
SAP 155 contacts pre-mRNA on both sides of the functional BPS in
A22/A14 pre-mRNA.
SAP 155 cross-links on
both sides of the BPS in functional A complex (Fig. 1). However, there
is no direct evidence that this interaction is essential for splicing.
To determine whether the cross-linking of SAP 155 to the pre-mRNA is
likely to be functionally important, we took advantage of the
observation that there are two potentially functional BPSs in
A22/A14 pre-mRNA, yet only the upstream one is
used for catalytic step I. We then asked where SAP 155 cross-links in
the A complex assembled on this pre-mRNA. The pre-mRNA was
32P site-specifically labeled at
6,
1, or +7 relative
to the A22 BPS and then assembled into the A complex (Fig.
7C). (Note that it was not possible to label downstream of the
A14 BPS because the pyrimidine sequence in this region
cannot be used as a transcription template for the site-specific
labeling [see Materials and Methods].) Strikingly, the data reveal
that SAP 155 cross-links on both sides of the functional
A22 BPS, and no cross-linking of SAP 155 is detected on the
upstream side of the nonfunctional A14 BPS (
1 site, Fig.
7C). Moreover, SAP 62, which cross-links at the
6 site on wild-type
pre-mRNA, is also detected at the
6 site of the functional BPS in
A22/A14 pre-mRNA (Fig. 7C). Thus, the wild-type
pattern of cross-linked proteins is observed surrounding the
functional, but not the nonfunctional, BPS in
A22/A14 pre-mRNA. Furthermore, as observed with
wild-type pre-mRNA (Fig. 1), the cross-linking efficiencies of SAP 155 are the same both upstream and downstream of the functional BPS in
A22/A14 pre-mRNA. Finally, the sequences where
SAP 155 cross-links are different in wild-type and
A22/A14 pre-mRNAs (compare schematics,
Fig. 1A and 7C). The latter observation argues that SAP 155-pre-mRNA
interactions on both sides of the BPS occur generally and are not
peculiar to one pre-mRNA sequence. Moreover, the observation that the
interaction between SAP 155 and the functional BPS is detected at a
time in the splicing reaction (the A complex) well prior to BPS use
(catalytic step I) is consistent with the proposal that SAP
155-pre-mRNA interactions play a role in recruiting U2 snRNP to the
BPS.
 |
DISCUSSION |
The BPS is highly degenerate in metazoan pre-mRNAs. Nevertheless,
this sequence element plays a critical role in splicing by base pairing
with U2 snRNA to specify the nucleophile for catalytic step I. Because
the BPS is so degenerate, specific mechanisms must exist for targeting
U2 snRNA to its binding site. Our data suggest a model for how U2 snRNP
is recruited to the BPS (Fig. 8). In the
E complex, U2AF binds to the pyrimidine tract and interacts directly
with SF1/mBBP (2, 4-6, 33). During the transition to the A
complex, U2AF recruits U2 snRNP through direct interactions with SAP
155 (Fig. 8). An amino-terminal region of SAP 155 and a
carboxy-terminal portion of U2AF65 (which contains the
third RRM) are necessary for this interaction. In addition, the amino
terminus of SAP 155 interacts with U2AF35. In the A
complex, SAP 155 contacts pre-mRNA on both sides of the BPS. SAP 155 and SF1/mBBP interact with the same region of U2AF65
(6). Thus, the SF1/mBBP-U2AF interaction in the E complex may be replaced by the SAP 155-U2AF interaction in the A complex. Annealing of U2 snRNA to the BPS may be achieved by a direct
interaction between the RS domain of U2AF65 and the BPS, as
recently proposed (Fig. 8) (28). Finally, the other SF3a and
-b subunits (SAPs 49, 61, 62, 114, and 145) function to anchor U2 snRNP
tightly to the pre-mRNA (15). The RNA-protein and
protein-protein interactions of these SF3a and -b proteins are thought
to fold the pre-mRNA into a distinct structure upstream of the branch
site (15). As indicated in the model, U2AF65 is
phosphorylated in the A complex and becomes less tightly bound to
pre-mRNA (8). Ultimately, U2AF is replaced by U5 snRNP
(9).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 8.
Model for recruitment of U2 snRNP. The 3' portion of the
intron containing the BPS and the pyrimidine (py) tract are shown. Only
the factors discussed in this study are indicated. Proteins that
interact directly are shown touching. P indicates the phosphorylation
of U2AF65 that occurs in the A complex. Note that
U2AF65 and U2AF35 are much less tightly bound
in the A complex than in the E complex. SAPs 49, 61, 62, 114, 145, and
155 are shown.
|
|
Parameters for BPS selection.
In order to determine parameters
important for U2 snRNP binding to the BPS and for BPS selection, we
analyzed a series of mutant pre-mRNAs. These studies yielded three key
results. First, insertion of a spacer between the BPS and pyrimidine
tract inhibits U2 snRNP binding. Second, in a pre-mRNA in which a
duplicate BPS is inserted upstream of the normal BPS, the one closer to
the pyrimidine tract is used. Third, a BPS located too close to the pyrimidine tract is not selected. Together, these data indicate that
recruitment of U2 snRNP to the BPS (and BPS selection) requires an
interaction between a factor(s) bound to the pyrimidine tract and a
factor(s) bound to the BPS. Moreover, the distance requirement indicates that this interaction is constrained linearly along the
pre-mRNA. Specifically, the data are not consistent with a mechanism in
which factors bound at the pyrimidine tract can interact with factors
bound at a distant BPS, with the intervening RNA looped out. The data
also indicate that there must be an optimal distance between the BPS
and pyrimidine tract, most likely to accommodate the factors bound at
each site. Our observations on the parameters for BPS selection (that
the nearest BPS to the pyrimidine tract is selected and that there are
constraints on the BPS-to-pyrimidine tract distance) could be explained
by SF1/mBBP-U2AF interactions, SAP 155-U2AF interactions, or both
(2, 5, 33, 34) (Fig. 8). At present, it is not possible to
distinguish between these and other possibilities.
Several observations are consistent with the model that SAP 155-U2AF
interactions function in recruiting U2 snRNP to the BPS. U2AF is
necessary for A complex assembly, and SAP 155 is a component of the
splicing factor SF3b, which is essential for A complex assembly (for
reviews, see references 17, 25, and
32). Temporally, U2AF cross-linking to the
pyrimidine tract precedes SAP 155 UV cross-linking on both sides of the
BPS. Moreover, the RNA-protein and protein-protein interactions of SAP
155 and U2AF appear to be functionally important for U2 snRNP binding.
First, in a pre-mRNA containing duplicated BPSs, SAP 155 interacts with
pre-mRNA on both sides of the functional BPS only. Second, a specific
domain on SAP 155 and a specific domain on U2AF are required for the SAP 155-U2AF interaction. Third, the SAP 155-U2AF interaction is
conserved in S. pombe. Significantly, S. pombe
SAP 155 and U2AF59 were recently shown to interact as
synthetic lethal mutants (27b), providing genetic evidence
for the importance of the SAP 155-U2AF65 interaction.
The amino terminus of SAP 155 is not conserved in S. cerevisiae, indicating that the same SAP 155-U2AF65
interactions that we have detected in S. pombe and humans
are not likely to be involved in recruiting U2 snRNP in S. cerevisiae. The S. cerevisiae BPS is stringently
conserved. Thus, it is possible that the U2 snRNA-BPS duplex and/or BBP
plays a role in recruiting U2 snRNP in yeast (2
[see reference 19 for review]). It is also
possible that interactions between MUD2 and the U2 snRNP protein PRP11
(the SAP 62 homolog) function in recruiting U2 snRNP in S. cerevisiae (1). The yeast splicing factor PRP5, which is a member of the DEAD box family of ATPases, is required for U2 snRNP
binding and mediates a conformational change in U2 snRNP (21,
31). Thus, this protein is another candidate for recruiting U2
snRNP. These observations, together with our data, indicate that the
specificity for U2 snRNP binding most likely involves the formation of
a vast number of RNA-RNA, RNA-protein, and protein-protein contacts.
We are grateful to Z. Zhou and K. Chua for useful discussions and
critical reading of the manuscript and to M. Rosbash and N. Abovich for
useful discussions and for the mBBP clone. We are grateful to Ron
McKinney for excellent technical assistance with the two-hybrid assays
of the S. pombe constructs.
This work was supported by an NIH grant to R.R. and an NIH grant
(R01GM47487) and ACS grant (JFRA-545) to J.P.
| 1.
|
Abovich, N.,
X. C. Liao, and M. Rosbash.
1994.
The yeast MUD2 protein: an interaction with PRP11 defines a bridge between commitment complexes and U2 snRNP addition.
Genes Dev.
8:843-854[Abstract/Free Full Text].
|
| 2.
|
Abovich, N., and M. Rosbash.
1997.
Cross-intron bridging interactions in the yeast commitment complex are conserved in mammals.
Cell
89:403-412[Medline].
|
| 3.
|
Bennett, M., and R. Reed.
1993.
Correspondence between a mammalian spliceosome component and an essential yeast splicing factor.
Science
262:105-108[Abstract/Free Full Text].
|
| 4.
|
Bennett, M.,
S. Michaud,
J. Kingston, and R. Reed.
1992.
Protein components specifically associated with prespliceosome and spliceosome complexes.
Genes Dev.
6:1986-2000[Abstract/Free Full Text].
|
| 5.
|
Berglund, J. A.,
K. Chua,
N. Abovich,
R. Reed, and M. Rosbash.
1997.
The splicing factor BBP interacts specifically with the pre-mRNA branchpoint sequence UACUAAC.
Cell
89:781-787[Medline].
|
| 6.
|
Berglund, J. A.,
N. Abovich, and N. Rosbash.
1998.
A cooperative interaction between U2AF65 and mBBP/SF1 facilitates branchpoint region recognition.
Genes Dev.
12:858-867[Abstract/Free Full Text].
|
| 7.
|
Brosi, R.,
H. P. Hauri, and A. Kramer.
1993.
Separation of splicing factor SF3 into two components and purification of SF3a activity.
J. Biol. Chem.
268:17640-17646[Abstract/Free Full Text].
|
| 8.
|
Champion-Arnaud, P.,
O. Gozani,
L. Palandjian, and R. Reed.
1995.
Accumulation of a novel spliceosomal complex on pre-mRNAs containing branch site mutations.
Mol. Cell. Biol.
15:5750-5756[Abstract].
|
| 9.
|
Chiara, M.,
L. Palandjian, and R. Reed.
1997.
Evidence the U5 snRNP recognizes the 3' splice site for catalytic step II in mammals.
EMBO J.
16:4746-4759[Medline].
|
| 10.
|
Chiara, M. D.,
P. Champion-Arnaud,
M. Buvoli,
B. Nadal-Ginard, and R. Reed.
1994.
Specific protein-protein interactions between the essential mammalian spliceosome-associated proteins SAP 61 and SAP 114.
Proc. Natl. Acad. Sci. USA
91:6403-6407[Abstract/Free Full Text].
|
| 11.
|
Chiara, M. D.,
O. Gozani,
M. Bennett,
P. Champion-Arnaud,
L. Palandjian, and R. Reed.
1996.
Identification of proteins that interact with exon sequences, splice sites, and the branchpoint sequence during each stage of spliceosome assembly.
Mol. Cell. Biol.
16:3317-3326[Abstract].
|
| 12.
|
Fields, S., and O. Song.
1989.
A novel genetic system to detect protein-protein interactions.
Nature
340:245-246[Medline].
|
| 13.
|
Fleckner, J.,
M. Zhang,
J. Valcarcel, and M. R. Green.
1997.
U2AF65 recruits a novel human DEAD box protein required for the U2 snRNP-branchpoint interaction.
Genes Dev.
11:1864-1872[Abstract/Free Full Text].
|
| 14.
|
Gozani, O.,
J. G. Patton, and R. Reed.
1994.
A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction.
EMBO J.
13:3356-3367[Medline].
|
| 15.
|
Gozani, O.,
R. Feld, and R. Reed.
1996.
Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A.
Genes Dev.
10:233-243[Abstract/Free Full Text].
|
| 16.
|
Kramer, A.
1992.
Purification of splicing factor SF1, a heat-stable protein that functions in the assembly of a presplicing complex.
Mol. Cell. Biol.
12:4545-4552[Abstract/Free Full Text].
|
| 17.
|
Kramer, A.
1996.
The structure and function of proteins involved in mammalian pre-mRNA splicing.
Annu. Rev. Biochem.
65:367-409[Medline].
|
| 18.
|
MacMillan, A. M.,
C. C. Query,
C. R. Allerson,
S. Chen,
G. L. Verdine, and P. A. Sharp.
1994.
Dynamic association of proteins with the pre-mRNA branch region.
Genes Dev.
8:3008-3020[Abstract/Free Full Text].
|
| 19.
|
Madhani, H. D., and C. Guthrie.
1994.
Dynamic RNA-RNA interactions in the spliceosome.
Annu. Rev. Genet.
28:1-26[Medline].
|
| 20.
|
Moore, M. J., and P. A. Sharp.
1992.
Site-specific modification of pre-mRNA: the 2'-hydroxyl groups at the splice sites.
Science
256:992-997[Abstract/Free Full Text].
|
| 21.
|
O'Day, C. L.,
G. Dalbadie-McFarland, and J. Abelson.
1996.
The Saccharomyces cerevisiae Prp5 protein has RNA-dependent ATPase activity with specificity for U2 small nuclear RNA.
J. Biol. Chem.
271:33261-33267[Abstract/Free Full Text].
|
| 22.
|
Potashkin, J.,
K. Naik, and K. Wentz-Hunter.
1993.
U2AF homolog required for splicing in vivo.
Science
262:573-575[Abstract/Free Full Text].
|
| 23.
|
Query, C. C.,
M. J. Moore, and P. A. Sharp.
1994.
Branch nucleophile selection in pre-mRNA splicing: evidence for the bulged duplex model.
Genes Dev.
8:587-597[Abstract/Free Full Text].
|
| 24.
|
Query, C. C.,
S. A. Strobel, and P. A. Sharp.
1996.
Three recognition events at the branch-site adenine.
EMBO J.
15:1392-1402[Medline].
|
| 25.
|
Reed, R.
1996.
Initial splice-site recognition and pairing during pre-mRNA splicing.
Curr. Opin. Genet. Dev.
6:215-220[Medline].
|
| 26.
|
Reed, R.
1989.
The organization of 3' splice-site sequences in mammalian introns.
Genes Dev.
3:2113-2123[Abstract/Free Full Text].
|
| 27.
|
Reed, R.
1990.
Protein composition of mammalian spliceosomes assembled in vitro.
Proc. Natl. Acad. Sci. USA
87:8031-8035[Abstract/Free Full Text].
|
| 27a.
|
Smith, C. W. J.,
E. B. Porro,
J. G. Patton, and B. Nadal-Ginard.
1989.
Scanning from an independently specified branchpoint defines the 3' splice site of mammalian introns.
Nature
342:243-247[Medline].
|
| 27b.
| Tani, T. Personal communication.
|
| 28.
|
Valcarcel, J.,
R. K. Gaur,
R. Singh, and M. R. Green.
1996.
Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA.
Science
273:1706-1709[Abstract/Free Full Text].
|
| 29.
|
Wang, C.,
K. Chua,
W. Seghezzi,
E. Lees, and R. Reed.
1998.
Phosphorylation of the spliceosomal protein SAP 155 coupled with splicing catalysis.
Genes Dev.
12:1409-1414[Abstract/Free Full Text].
|
| 30.
|
Wentz-Hunter, K., and J. Potashkin.
1996.
The small subunit of the splicing factor U2AF is conserved in fission yeast.
Nucleic Acids Res.
24:1849-1854[Abstract/Free Full Text].
|
| 31.
|
Wiest, D. K.,
C. L. O'Day, and J. Abelson.
1996.
In vitro studies of the Prp9.Prp11.Prp21 complex indicate a pathway for U2 small nuclear ribonucleoprotein activation.
J. Biol. Chem.
271:33268-33276[Abstract/Free Full Text].
|
| 32.
|
Will, C. L., and R. Luhrmann.
1997.
Protein functions in pre-mRNA splicing.
Curr. Opin. Cell Biol.
9:320-328[Medline].
|
| 33.
|
Zamore, P. D., and M. R. Green.
1991.
Biochemical characterization of U2 snRNP auxiliary factor: an essential pre-mRNA splicing factor with a novel intranuclear distribution.
EMBO J.
10:207-214[Medline].
|
| 34.
|
Zamore, P. D.,
J. G. Patton, and M. R. Green.
1992.
Cloning and domain structure of the mammalian splicing factor U2AF.
Nature
355:609-614[Medline].
|
| 35.
|
Zhang, M.,
P. D. Zamore,
M. Carmo-Fonseca,
A. I. Lamond, and M. R. Green.
1992.
Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunit.
Proc. Natl. Acad. Sci. USA
89:8769-8773[Abstract/Free Full Text].
|
| 36.
|
Zuo, P., and T. Maniatis.
1996.
The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing.
Genes Dev.
10:1356-1368[Abstract/Free Full Text].
|